Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-06
2007-02-06
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S212070, C540S523000, C540S594000
Reexamination Certificate
active
10967567
ABSTRACT:
The present invention relates to novel benzazepine derivatives of the following formula:wherein R1, R2, R3, R4and R5, X, X′, Y and Y′ are as defined in the description and claims, processes for their preparation, pharmaceutical compositions containing said derivatives and their use for the preparation of medicaments useful for the prevention and treatment of diseases in which selective inhibition of monoamine oxidase B activity plays a role or is implicated.
REFERENCES:
patent: 3719669 (1973-03-01), Shetty
patent: 4210749 (1980-07-01), Shetty
patent: 4287351 (1981-09-01), Bourgery et al.
patent: 4524206 (1985-06-01), New et al.
patent: 4764522 (1988-08-01), Kyburz et al.
patent: 4776876 (1988-10-01), Nordhoff et al.
patent: 4906626 (1990-03-01), Amrein et al.
patent: 5100914 (1992-03-01), Rendenbach-Mueller et al.
patent: 5304556 (1994-04-01), Yamamoto et al.
patent: 5317017 (1994-05-01), Ok et al.
patent: 5416112 (1995-05-01), Kuo
patent: 5446066 (1995-08-01), Varasi et al.
patent: 5731324 (1998-03-01), Fisher
patent: 5889026 (1999-03-01), Alanine et al.
patent: 6020362 (2000-02-01), Fisher
patent: 6137002 (2000-10-01), Fisher et al.
patent: 6448269 (2002-09-01), Fisher et al.
patent: 6472405 (2002-10-01), Fisher
patent: 6660736 (2003-12-01), Cesura et al.
patent: 6667327 (2003-12-01), Cesura et al.
patent: 6762320 (2004-07-01), Jolidon et al.
patent: 6818774 (2004-11-01), Cesura et al.
patent: 6953787 (2005-10-01), Smith et al.
patent: 1003753 (1957-03-01), None
patent: 0326023 (1989-08-01), None
patent: 03633793 (1990-04-01), None
patent: 0400495 (1990-12-01), None
patent: 0504574 (1992-09-01), None
patent: 0632017 (1995-01-01), None
patent: 0635492 (1995-01-01), None
patent: 0754455 (1997-01-01), None
patent: 0985665 (2000-03-01), None
patent: 2500831 (1982-09-01), None
patent: 2645019 (1990-10-01), None
patent: 2-142774 (1990-05-01), None
patent: 5-262718 (1993-10-01), None
patent: WO 90/11997 (1990-10-01), None
patent: WO 99/14334 (1990-11-01), None
patent: WO 92/05163 (1992-04-01), None
patent: WO 9304686 (1993-03-01), None
patent: WO 96/22288 (1996-07-01), None
patent: WO 96/40095 (1996-12-01), None
patent: WO 97/05102 (1997-02-01), None
patent: WO 97/33572 (1997-09-01), None
patent: WO 99/10349 (1999-03-01), None
patent: WO 99/26614 (1999-06-01), None
patent: WO 99/35123 (1999-07-01), None
patent: WO 99/54279 (1999-10-01), None
patent: WO 00/75106 (2000-12-01), None
patent: WO 01/32649 (2001-05-01), None
patent: WO 01/34172 (2001-05-01), None
patent: WO 01/56560 (2001-08-01), None
patent: WO 03/080573 (2003-10-01), None
patent: WO 03/080573 (2003-10-01), None
patent: WO 2004/056369 (2004-07-01), None
patent: WO 2005042491 (2005-05-01), None
Citation “O”, WO2005/082859A1 is not being furnished with this Action because the publication is 550+ pages. See HCAPLUS, Accession No. 2005 979618 Attached to Action.
Bach, A. W. J., et al. Proc. Natl. Acad. Sci. USA 85:4934-4938 (1988).
Cesura, A. M., & Pletscher, A., Prog. Drug Research 38:171-297 (1992).
Fowler, C. J., et al. J. Neural. Transm. 49:1-20 (1980).
Benedetti, M. S., et al. Biochem. Pharmacol. 38:555-561 (1989).
Saura, J., et al. Neuroscience 70:755-774 (1996).
Bentué-Ferrer, D., et al. CNS Drugs 6(3): 217-236 (1996).
Gardner, D. M., et al. J. Clin. Psychiatry 57(3):99-104 (1996).
Cesura, et al., Eur J. Pharmacol. vol. 162, pp. 457-465 (1989).
Pecherer B. et al., J. Heterocycl. Chem. vol. 8(5) pp. 779-783 (1971).
Reiffen et al., J. Med. Chem. vol. 33(5) pp. 1496-1504 (1990).
Mannekens, E. et al., Synthesis vol. 9, pp. 1214-1216 (2000).
Fukumi, H. et al., Heterocycles vol. 9(9) pp. 1197-1206 (1978).
Fürstner, A. et al., Chemistry, A European Journal vol. 7(24) pp. 5286-5298 (2001).
Roy, S.C., et al, Tetrahedron Letters vol. 42(52) p. 9253-9255 (2001).
Suzuki, H. et al., Synthesis vol. 3, pp. 236-238 (1988).
Judeh, Z. M. et al., Tetrahedron Letters, vol. 43(29) pp. 5089-5091 (2002).
Okuda, K. et al., Bioorg. Med. Chem. Letters vol. 13(17) pp. 2853-2855 (2003).
J. Org. Chem. vol. 53, No. 24, pp. 5793-5796 (1988).
Zhou, M., & Panchuk-Voloshina, N., Analytical Biochemistry 253:169-174 (1997).
Schlaeger, E. J., & Christensen, K., Cytotechnology 30:71-83 (1999).
Grethe et al., J. Org. Chem. 33: 494-503 (1968).
Gnerre C. et al., Journal of Med. Chem. vol. 43 No. 25 pp. 4747-4758 (2000).
Cahn et al., Angew Chem. vol. 5, No. 4 pp. 385-415 (1966).
Cahn & Ingold, J. Chem. Soc. (London) pp. 612-622 (1951).
Cahn, et al., Experientia, vol. 12, pp. 81-124 (1956).
Cahn, J. Chem. Educ. vol. 41, pp. 116-125 (1964).
Fisher et al., Bioorganic and Medicinal Chem. Ltrs. vol. 7, No. 19 pp. 2537-2542 (1997).
Kalgutkar et al., Medicinal Research Reviews vol. 15, No. 4 pp. 325-388 (1995).
Foley, et al., Elsevier Science vol. 6, No. 1 pp. 25-47 (2000) (XP00087269).
Bentley et al., J. Chem. Soc. (C) 1969, pp. 2233-2234.
Krishnamurthy et al., Tetrahedron Lett. 1982, 23, pp. 3315-3318.
Lam et al., Tetrahedron Lett., 2002, 43, pp. 3091-3094.
Lam et al., Synlett, 2000, 5, pp. 674-676.
Chan et al., Tetrahedron Lett. 1998, 39, pp. 2933-2936.
Wolfe, J. P. ,et al. J. Amer. Chem. Soc. 118:7215-7216 (1996).
Ehrhardt, J. D. et al., European Journal of Medicinal Chem. vol. 13(3) pp. 235-240 (1978) (XP009018741).
Trivedi, J. P. et al., Indian Journal of Applied Chemistry, vol. 30(3-4) pp. 91-95 (1967) (XP009018747).
Lukas, A. et al., Acta Facultatis Pharm. Univ. Comenianae vol. 28, pp. 91-114 (1975) (XP00155612).
Lukas A. et al., Ceskoslov. Farm. vol. 13 pp. 225-228 (1964) (XP009018756).
Lukas, A. et al., Ceskoslov. Farm. vol. 21, No. 6, pp. 273-275. (1972) (XP009018758).
Lukas A. et al., Acta Facultatis Pharm. Bohemoslovenicae, vol. 12 pp. 189-202 (1966) (XP001155535).
Dostert P. et al., International Congress Series vol. 564, pp. 197-208 (1982) (XP001027632).
Abstract corresponding to JP 5-262718 (B24).
Greenspan et al. J. Med. Chem. 42: p. 164-172 (1999).
Drechsler et al., Eur. J. Org. Chem. p. 3441-3453 (1999).
Austin et al., J. Org. Chem. 46: p. 2280-2286 (1981).
Eckert et al., Synth. Commun. 28(2), pp. 327-335 (1998).
Jaen, J. et al., J. Med. Chem. 31: p. 1621-1625 (1988).
Rano, T. et al., Tetrahedron Letters vol. 36(22) pp. 3789-3792 (1995).
Ikuta, H., et al. J. Med. Chem. 30:1995-1998 (1987).
Danishefsky, S., et al. J. Amer. Chem. Soc. 97:3239-3241 (1975).
Freidinger, R. M., et al. J. Org. Chem. 47:104-109 (1982).
Abstract Corresponding to EP 0 985 665.
Ishibashi et al., Chem. Pharm Bull. vol. 37(4) pp. 939-943 (1989).
Abstract corresponding to JP 2-142774 (B7).
Abstract corresponding to WO 90/11997 (B27).
Abstract corresponding to FR 2500831 (B29).
Abstract corresponding to WO 01/32649 (B5).
Abstract corresponding to WO 90/11997 (B26).
Abstract corresponding to DE 1 003 753 (B22).
Jolidon Synese
Rodriguez Sarmiento Rosa Maria
Thomas Andrew William
Wostl Wolfgang
Wyler Rene
Grazier Nyeemah
Hoffmann-La Roche Inc.
Johnston George W.
McKane Joseph K.
Prior Kimberly J.
LandOfFree
Bicyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3808763